Literature DB >> 17377385

Concurrence of systemic lupus erythematosus and pemphigus: coincidence or correlation?

Mohsin Malik1, A Razzaque Ahmed.   

Abstract

BACKGROUND: Pemphigus and systemic lupus erythematosus (SLE) have previously been reported to coexist in the same patient. However, the relationship between the 2 diseases has not been elucidated.
OBJECTIVE: This review was conducted to examine the relationship between pemphigus and SLE when they occur together in the same patient.
METHODS: We conducted a retrospective review of the literature to identify previously reported cases of pemphigus and SLE coexisting in the same patient. The temporal relationship, clinical course, response to therapy and effects of 1 disease on the other were examined.
RESULTS: Eight patients with a dual diagnosis of pemphigus and SLE have been previously reported. Most were female and non-Caucasian, with a mean age of 41 years. In the 8 patients reviewed here clinical outcomes, organ system involvement and demographic profiles are more typical of SLE. Seven of these 8 patients had pemphigus vulgaris, and 1 had pemphigus erythematosus. The limited follow-up did not permit studying issues of disease interaction. An additional 17 patients with pemphigus have been reported who have features suggestive of SLE. Organ system involvement in these patients was less typical of SLE.
CONCLUSION: It appears that a true dual diagnosis of pemphigus and SLE is less common than suggested by the literature. Comparing patients with only pemphigus or only SLE to those with both may provide insights into genetic predisposition and pathogenesis, and provide an opportunity to study the effects of drugs that influence their course. Copyright (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 17377385     DOI: 10.1159/000099588

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  9 in total

1.  Relationship between target antigens and major histocompatibility complex (MHC) class II genes in producing two pathogenic antibodies simultaneously.

Authors:  L R Zakka; D B Keskin; P Reche; A R Ahmed
Journal:  Clin Exp Immunol       Date:  2010-11       Impact factor: 4.330

Review 2.  [Lupus erythematosus. Wide range of symptoms through clinical variation, associated diseases and imitators].

Authors:  E Aberer
Journal:  Hautarzt       Date:  2010-08       Impact factor: 0.751

3.  The relationship between pemphigus and systemic lupus erythematosus: a cross-sectional study, systematic review, and meta-analysis.

Authors:  Khalaf Kridin; Rimma Laufer-Britva; Mouhammad Kridin; Doron Comaneshter; Erez Batat; Arnon D Cohen
Journal:  Immunol Res       Date:  2019-02       Impact factor: 2.829

Review 4.  Refractory pemphigus foliaceus and Behçet's disease successfully treated with tocilizumab.

Authors:  Francesco Caso; Luca Iaccarino; Silvano Bettio; Francesca Ometto; Luisa Costa; Leonardo Punzi; Andrea Doria
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

5.  Pemphigus erythematosus relapse associated with atorvastatin intake.

Authors:  Ada Lo Schiavo; Rosa Valentina Puca; Francesca Romano; Roberto Cozzi
Journal:  Drug Des Devel Ther       Date:  2014-09-18       Impact factor: 4.162

6.  Vesiculobullous diseases in relation to lupus erythematosus.

Authors:  Suthinee Rutnin; Kumutnart Chanprapaph
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-09-04

Review 7.  Autoimmune Pemphigus: Latest Advances and Emerging Therapies.

Authors:  Yen Loo Lim; Gerome Bohelay; Sho Hanakawa; Philippe Musette; Baptiste Janela
Journal:  Front Mol Biosci       Date:  2022-02-04

8.  Immunogenetic mechanisms for the coexistence of organ-specific and systemic autoimmune diseases.

Authors:  Masha Fridkis-Hareli
Journal:  J Autoimmune Dis       Date:  2008-02-15

9.  Gene Expression Analysis Reveals Novel Shared Gene Signatures and Candidate Molecular Mechanisms between Pemphigus and Systemic Lupus Erythematosus in CD4+ T Cells.

Authors:  Tanya Sezin; Artem Vorobyev; Christian D Sadik; Detlef Zillikens; Yask Gupta; Ralf J Ludwig
Journal:  Front Immunol       Date:  2018-01-17       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.